Endocrine Metabolic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC74-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Assess glycemic status against the ordered parameters and document the skilled judgment:

  • Blood-glucose values and the trend against the ordered parameters and the sliding-scale/titration order; insulin administered (type, dose, site) and the response.
  • Signs of hypoglycemia (diaphoresis, tremor, confusion) and hyperglycemia (polyuria, thirst, lethargy); intake relative to the insulin plan (route nutrition detail to Nutrition).
  • For thyroid/electrolyte disorders, the relevant symptoms and the monitoring parameters and labs.

MDS-supportive data

Insulin days and the number of insulin injections are coded in MDS Section N; IV medication in Section O; the endocrine diagnosis in Section I. The record must document the glucose values, insulin administration, and response so Section N is supported.

Section NavigationPart 3 of 15PreviousNext